Related Experiment Video
Updated: Sep 16, 2025

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
Calf circumference predicts sarcopenia and all-cause mortality in older patients undergoing maintenance hemodialysis:
Yan Shen1,2, Hongmin Qin2, Xiaosu Liu2
1Department of Nephrology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
Insights
Calf circumference (CC) effectively predicts sarcopenia and mortality in older patients on maintenance hemodialysis (MHD). Lower CC is linked to higher risks, establishing it as a crucial health indicator for this population.
Area of Science:
- Gerontology
- Nephrology
- Clinical Nutrition
Background:
- The predictive role of calf circumference (CC) for sarcopenia and mortality in maintenance hemodialysis (MHD) patients is debated.
- This study aimed to evaluate CC's predictive value, optimal thresholds, and association with mortality in older MHD patients.
Purpose of the Study:
- To assess calf circumference as a predictor of sarcopenia in older adults undergoing maintenance hemodialysis.
- To determine the optimal calf circumference thresholds for identifying sarcopenia in male and female MHD patients.
- To investigate the association between calf circumference, sarcopenia, and 2-year mortality in this patient group.
Main Methods:
- An observational cohort study involving 979 older adult MHD patients.
- Sarcopenia diagnosis based on the European Working Group on Sarcopenia in Older People criteria.
- Logistic regression, ROC analysis, Kaplan-Meier, and Cox regression were used to analyze CC, sarcopenia, and mortality.
Main Results:
- Sarcopenia prevalence was 61.1% in the study population.
- Low calf circumference (CC) and sarcopenia were independent predictors of mortality in older MHD patients.
- Optimal CC cutoffs were identified as 32.5 cm for men and 31.9 cm for women, with high sensitivity and specificity.
Conclusions:
- Calf circumference is a valuable and independent predictor of sarcopenia in older patients undergoing maintenance hemodialysis.
- Reduced calf circumference is significantly associated with increased mortality risk in this vulnerable patient population.
Background:
The role of calf circumference (CC) in predicting sarcopenia and mortality of patients undergoing maintenance hemodialysis (MHD) remains debated. This study assessed CC's predictive value, optimal threshold, and mortality association in older patients undergoing MHD.
Methods:
An observational cohort study was conducted on older adult patients undergoing MHD. Sarcopenia was defined by European Working Group on Sarcopenia in Older People. Logistic regression and receiver operating characteristic (ROC) analysis were used to explore the relationship between CC and sarcopenia. Kaplan-Meier and Cox regression analyses assessed survival over 2 years.
Results:
A total of 979 older adult patients undergoing MHD treatment, with an average age of 73.4 years, were included in this study. The prevalence of sarcopenia was 61.1%. Male sex (odds ratio [OR], 0.17; 95% confidence interval [CI], 0.04-0.45; P = 0.017) and CC (OR, 0.38; 95% CI, 0.26-0.56; P < 0.001) were identified as independent risk factors for sarcopenia through multifactorial logistic regression analysis. ROC curves for CC and sarcopenia indicated that the optimal cutoff value for men was 32.5 cm (area under the curve [AUC], 0.904; sensitivity, 0.958; specificity, 0.841), whereas for women, it was 31.9 cm (AUC, 0.884; sensitivity, 0.922; specificity: 0.756). Kaplan-Meier survival analysis demonstrated lower survival probabilities in patients with sarcopenia and low CC. After adjustment for multiple factors, Cox regression analysis revealed that patients in the sarcopenia group (hazard ratio [HR] = 2.411; P = 0.017) and those in the low-CC group (HR = 2.045; P = 0.046) had significantly shorter overall survival.
Conclusions:
CC is an independent predictor of sarcopenia and mortality in older patients undergoing MHD.
Related Concept Videos
Hemodialysis III: Nursing Management
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Chronic Kidney Disease II: Clinical Manifestations
Nephrotic Syndrome III : Nursing Management

